Page 5 - High Acuity News Today

Oppenheimer Asset Management Inc. lowered its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 1.7% in the 2nd quarter, HoldingsChannel reports. The fund owned 69,083 shares of the health services provider’s stock after selling 1,195 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Amedisys were worth $6,317,000 as of its most recent […]

Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings data on Tuesday. The health services provider reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.10), Briefing.com reports. Amedisys had a net margin of 0.10% and a return on equity of 14.00%. The firm had revenue of $556.24 […]

StockNews.com initiated coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research note published on Sunday morning. The firm issued a buy rating on the health services provider’s stock. Other research analysts have also issued research reports about the stock. Jefferies Financial Group lowered shares of Amedisys from a buy rating to a […]

StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a report published on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other equities analysts have also recently issued reports on the stock. Jefferies Financial Group cut shares of Amedisys from a buy rating […]

StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Free Report) in a research report sent to investors on Saturday morning. The brokerage issued a buy rating on the health services provider’s stock. A number of other research firms have also recently commented on AMED. Jefferies Financial Group cut Amedisys from a buy rating to […]

Riverbridge Partners LLC increased its position in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,559,572 shares of the health services provider’s stock after acquiring an additional 34,261 shares during the period. Amedisys comprises about […]

Shares of Amedisys, Inc. (NASDAQ:AMED – Get Free Report) have earned an average recommendation of “Hold” from the thirteen analysts that are currently covering the company, Marketbeat reports. Ten analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month target price among […]

Several analysts have recently updated their ratings and price targets for Amedisys (NASDAQ: AMED): 9/21/2023 – Amedisys is now covered by analysts at StockNews.com. They set a “buy” rating on the stock. 9/14/2023 – Amedisys had its price target raised by analysts at Cantor Fitzgerald from $100.00 to $101.00. They now have a “neutral” rating […]

SG Americas Securities LLC grew its stake in shares of Amedisys, Inc. (NASDAQ:AMED – Free Report) by 2,744.5% in the second quarter, Holdings Channel.com reports. The fund owned 113,553 shares of the health services provider’s stock after buying an additional 109,561 shares during the quarter. SG Americas Securities LLC’s holdings in Amedisys were worth $10,383,000 […]

Equities researchers at StockNews.com started coverage on shares of Amedisys (NASDAQ:AMED – Get Free Report) in a report released on Wednesday. The firm set a “buy” rating on the health services provider’s stock. AMED has been the subject of a number of other research reports. Barclays boosted their price target on Amedisys from $88.00 to […]